Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke

被引：9
|
作者：
Hallevi, Hen [1 ]
Grotta, James C. [1 ]
机构：
[1] Univ Texas Houston, Vasc Neurol Program, Houston, TX 77030 USA
来源：
ARCHIVES OF NEUROLOGY | 2008年 / 65卷 / 05期
关键词：
D O I：
10.1001/archneur.65.5.575
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [21] Intravenous Tissue Plasminogen Activator Therapy for an Acute Ischemic Stroke Patient with Later Diagnosed Unilateral Moyamoya Syndrome
    Yokoyama, Shota
    Manabe, Yasuhiro
    Fujii, Daiki
    Ikeda-Sakai, Yasuko
    Narai, Hisashi
    Omori, Nobuhiko
    Abe, Koji
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07): : 1190 - 1192
  • [22] Asymptomatic Hemorrhagic Infarction on 24-Hour CT Post Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Predicts Symptomatic Intracerebral Hemorrhage After Initiation of Antiplatelet Therapy.
    Ricci, Brittany
    Mac Grory, Brian
    Chang, Andrew
    Cutting, Shawna
    Burton, Tina
    Dakay, Katarina
    McTaggart, Ryan
    Jayaraman, Mahesh
    Reznik, Michael
    Thompson, Bradford
    Wendell, Linda
    Mahta, Ali
    Rao, Shyam
    Potter, Stevenson
    Sheth, Kevin N.
    Willey, Joshua
    Khatri, Pooja
    Furie, Karen
    Yaghi, Shadi
    STROKE, 2019, 50
  • [23] Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction
    Gurwitz, JH
    Gore, JM
    Goldberg, RJ
    Barron, HV
    Breen, T
    Rundle, AC
    Sloan, MA
    French, W
    Rogers, WJ
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (08) : 597 - +
  • [24] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [25] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [26] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [27] The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke
    Kahn, JH
    Viereck, J
    Kase, C
    Jeerakathil, T
    Romero, R
    Mehta, SD
    Kociol, R
    Babikian, V
    JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03): : 273 - 277
  • [28] Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
    Tseng, Yi-Ju
    Hu, Ru-Fang
    Lee, Shin-Tyng
    Lin, Yu-Li
    Hsu, Chien-Lung
    Lin, Shih-Wei
    Liou, Chia-Wei
    Lee, Jiann-Der
    Peng, Tsung-I
    Lee, Tsong-Hai
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (02)
  • [29] Outcomes of Patients with Bridging Therapy after Administration of Intravenous Tissue Plasminogen Activator in Patients with Severe Ischemic Stroke
    Tafish, Islam
    Hassan, Ameer
    Tohidi, Vahid
    Kirmani, Jawad
    NEUROLOGY, 2009, 72 (11) : A289 - A289
  • [30] Outcomes of patients with Bridging Therapy after Administration of Intravenous Tissue Plasminogen Activator In Patients With Severe Ischemic Stroke
    Tafish, Islam
    Mughni, Azam
    Ahmad, Hamad
    Hassan, Ameer
    Tohidi, Vahid
    Kirmani, Jawad
    STROKE, 2009, 40 (04) : E204 - E204
12345